Precision Biosciences (DTIL) Free Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.09% |
| Dec 31, 2025 | 26.20% |
| Sep 30, 2025 | 24.68% |
| Jun 30, 2025 | -6.05% |
| Mar 31, 2025 | -1.79% |
| Dec 31, 2024 | -215.58% |
| Sep 30, 2024 | 60.05% |
| Jun 30, 2024 | 21.87% |
| Mar 31, 2024 | -127.07% |
| Dec 31, 2023 | 64.24% |
| Sep 30, 2023 | -5.71% |
| Jun 30, 2023 | 30.56% |
| Mar 31, 2023 | -42.31% |
| Dec 31, 2022 | -179.99% |
| Sep 30, 2022 | 212.37% |
| Jun 30, 2022 | 15.79% |
| Mar 31, 2022 | -17.88% |
| Dec 31, 2021 | -2.22% |
| Sep 30, 2021 | 25.40% |
| Jun 30, 2021 | -149.34% |
| Mar 31, 2021 | 560.18% |
| Dec 31, 2020 | 37.48% |
| Sep 30, 2020 | 15.65% |
| Jun 30, 2020 | -2.12% |
| Mar 31, 2020 | -3.56% |
| Dec 31, 2019 | -31.11% |
| Sep 30, 2019 | 19.49% |
| Jun 30, 2019 | 1.11% |
| Mar 31, 2019 | -9.68% |
| Dec 31, 2018 | -28.67% |
| Sep 30, 2018 | -69.64% |
| Jun 30, 2018 | 30.75% |